Results 281 to 290 of about 17,262,511 (380)
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Efficacy of Minocycline Hydrochloride Aspiration Sclerotherapy for Symptomatic Simple Hepatic Cysts: Does Clinical Outcome Vary With the Number of Injections? [PDF]
Azami T +5 more
europepmc +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Clinical outcome after entero-enteric anastomosis for Crohn's disease: a case-control study. [PDF]
Neri B +13 more
europepmc +1 more source
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra +10 more
wiley +1 more source
Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimab. [PDF]
Blauvelt A +8 more
europepmc +1 more source
Do JIA core outcome variables at baseline predict clinically inactive disease states at one year?
Mcdonagh, Janet
openalex +1 more source

